Prognostic classification of breast ductal carcinoma-in-situ

Lancet. 1995 May 6;345(8958):1154-7. doi: 10.1016/s0140-6736(95)90982-6.

Abstract

We present a new prognostic classification designated the Van Nuys classification for ductal carcinoma-in-situ (DCIS). The classification combines high nuclear grade and comedo-type necrosis to predict clinical recurrence. Three groups of DCIS patients were defined by the presence or absence of high nuclear grade and comedo-type necrosis: 1--non-high-grade DCIS without comedo-type necrosis, 2--non-high-grade DCIS with comedo-type necrosis, 3--high-grade DCIS with or without comedo-type necrosis. There were 31 local recurrences in 238 patients after breast-conservation surgery 3.8% (3/80) in group 1, 11.1% (10/90) in group 2, and 26.5% (18/68) in group 3. The 8-year actuarial disease-free survivals were 93%, 84%, and 61%, respectively (all p < or = 0.05). The Van Nuys classification defines three distinct and easily recognisable groups, each of which has a different likelihood of local recurrence if treated with breast conservation.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Bone Neoplasms / secondary
  • Breast Neoplasms / classification*
  • Breast Neoplasms / pathology*
  • Breast Neoplasms / therapy
  • Carcinoma in Situ / classification*
  • Carcinoma in Situ / pathology*
  • Carcinoma in Situ / secondary
  • Carcinoma in Situ / therapy
  • Carcinoma, Ductal, Breast / classification*
  • Carcinoma, Ductal, Breast / pathology*
  • Carcinoma, Ductal, Breast / secondary
  • Carcinoma, Ductal, Breast / therapy
  • Combined Modality Therapy
  • Disease-Free Survival
  • Humans
  • Mastectomy
  • Mastectomy, Segmental
  • Necrosis
  • Neoplasm Recurrence, Local
  • Prognosis
  • Prospective Studies